Their results showed more tumor-infiltrating immune-stimulatory cells, especially CD8+ cytotoxic T-lymphocyte, were recruited and triggered the release of anti-tumor cytokines, magnifying the anti-tumor effect. Here, CD8A is linked to neoplasm.